Shots:

• The company has launched the cobas SARS-CoV-2 variant set 1 test to detect spike mutations in virus variants including UK (B.1.1.7)- South Africa (B.1.351)- and Brazil (P.1)
• The accurate detection and differentiation of SARS-CoV-2 mutations can aid in assessing the spread of circulating variants and monitor their potential impact on diagnostics- vaccines and therapeutics
• The cobas SARS-CoV-2 variant set 1 test runs on the high-volume cobas 6800/8800 systems and is for research purposes only. The periodic assessments against emerging variants demonstrated Roche’s test is accurate and effective

 ­ Ref: Roche | Image: Roche